155 related articles for article (PubMed ID: 29286108)
41. LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression.
Lu QC; Rui ZH; Guo ZL; Xie W; Shan S; Ren T
J Cell Mol Med; 2018 Mar; 22(3):1527-1537. PubMed ID: 29266795
[TBL] [Abstract][Full Text] [Related]
42. miR-451a is downregulated and targets PSMB8 in prostate cancer.
Liu Y; Yang HZ; Jiang YJ; Xu LQ
Kaohsiung J Med Sci; 2020 Jul; 36(7):494-500. PubMed ID: 32128987
[TBL] [Abstract][Full Text] [Related]
43. CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.
Yao Y; Hua Q; Zhou Y
Biochem Biophys Res Commun; 2019 Jan; 508(1):37-45. PubMed ID: 30470570
[TBL] [Abstract][Full Text] [Related]
44.
Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
[TBL] [Abstract][Full Text] [Related]
45. Inhibiting microRNA-301b suppresses cell growth and targets RNF38 in cervical carcinoma.
Guo WL; Li N; Ma JL; Chen XM; Shi FY
Kaohsiung J Med Sci; 2020 Nov; 36(11):878-884. PubMed ID: 32643846
[TBL] [Abstract][Full Text] [Related]
46. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
[TBL] [Abstract][Full Text] [Related]
47. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Zhao X; Li X; Zhou L; Ni J; Yan W; Ma R; Wu J; Feng J; Chen P
Cancer Sci; 2018 Oct; 109(10):3068-3079. PubMed ID: 30099826
[TBL] [Abstract][Full Text] [Related]
48. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive analysis of aberrantly expressed microRNA profiles reveals potential biomarkers of human lung adenocarcinoma progression.
Sui J; Yang RS; Xu SY; Zhang YQ; Li CY; Yang S; Yin LH; Pu YP; Liang GY
Oncol Rep; 2017 Oct; 38(4):2453-2463. PubMed ID: 28791371
[TBL] [Abstract][Full Text] [Related]
50. miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R
J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690
[TBL] [Abstract][Full Text] [Related]
51. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
[TBL] [Abstract][Full Text] [Related]
52. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
[TBL] [Abstract][Full Text] [Related]
53. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
[TBL] [Abstract][Full Text] [Related]
55. miR‑379 inhibits cell proliferation and epithelial‑mesenchymal transition by targeting CHUK through the NF‑κB pathway in non‑small cell lung cancer.
Liu B; Wang Z; Cheng S; Du L; Yin Y; Yang Z; Zhou J
Mol Med Rep; 2019 Aug; 20(2):1418-1428. PubMed ID: 31173238
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
[TBL] [Abstract][Full Text] [Related]
57. Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma.
Song TT; Xu F; Wang W
Kaohsiung J Med Sci; 2020 Jul; 36(7):501-507. PubMed ID: 32196955
[TBL] [Abstract][Full Text] [Related]
58. MiR-579 Inhibits Lung Adenocarcinoma Cell Proliferation and Metastasis via Binding to CRABP2.
Yi Q; Miao Y; Kong Y; Xu Y; Zhou J; Dong Q; Liu H
Comput Math Methods Med; 2022; 2022():9111681. PubMed ID: 35966249
[TBL] [Abstract][Full Text] [Related]
59. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.
Dong HX; Wang R; Jin XY; Zeng J; Pan J
J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA‑1288 promotes cell proliferation of human glioblastoma cells by repressing ubiquitin carboxyl‑terminal hydrolase CYLD expression.
Yin J; Weng C; Ma J; Chen F; Huang Y; Feng M
Mol Med Rep; 2017 Nov; 16(5):6764-6770. PubMed ID: 28901464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
